Skip to content
★ Sign in to follow
MW

Marc Wilson

Chief Financial Officer
Total declarations
22
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (9 ops.)
€6.1M

Latest filing published 30 Sept 2024 for Crinetics Pharmaceuticals, Inc., €342k.

Filing timeline

BuySale
Marc Wilson

Insider track record

Disclosed buys
0
Disclosed sells
9

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Marc Wilson: trading record in brief

Marc Wilson is a declared insider at 2 companies (finance chief); the most frequent names are Crinetics Pharmaceuticals, Inc. and Cidara Therapeutics, Inc. The record holds 22 filings, for trades running from 18 September 2017 to 26 September 2024.

The open-market record consists of 9 sales worth €6.1M, with no purchase. Other entries cover 6 share grants and 7 option exercises. So far in 2024, the count stands at no purchases and 6 sales.

On 30 September 2024 came the latest disclosure, an open-market sale for €1.1M in Crinetics Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Marc Wilson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total

12 of 12 declarations